Position in GALT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$224,260
+$204,251 QoQ
Shares Held
48,332
+194.7% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 98 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in GALT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. GALT ranks #232 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in GALT
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $224,260 | 48,332 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $20,009 | 16,401 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $22,613 | 17,530 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $47,877 | 17,410 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $43,561 | 19,275 | Shares | Sole | 2024-08-01 | |
| 2021-03-31 | $66,595 | 30,689 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $63,311 | 28,264 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $67,908 | 25,434 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $97,304 | 31,799 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $60,364 | 30,798 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||